Metastatic lung lesions as a preferred resection site for immunotherapy with tumor infiltrating lymphocytes

Journal of Immunotherapy

Volumn 39, Issue 5, 2016, Pages 218-222

  Ben Avi, Ronny ^a   Itzhaki, Orit ^b   Simansky, David ^a   Zippel, Dov ^a   Markel, Gal ^b,c   Nun, Alon Ben ^a   Schachter, Jacob ^b   Besse, Michal J ^b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b Ella Lemelbaum Institute of Melanoma   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adoptive cell therapy; Tumor infiltrating lymphocytes; Video assisted thoracic surgery

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; INTERLEUKIN 2;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURGERY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LUNG PARENCHYMA; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; NONMYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE; TUMOR BIOPSY; ADOPTIVE IMMUNOTHERAPY; BIOPSY; CANCER STAGING; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; CYTOTOXICITY; IMMUNOLOGY; LUNG RESECTION; LUNG TUMOR; MELANOMA; PATHOLOGY; PROCEDURES; SECONDARY; SURVIVAL ANALYSIS; TRANSPLANTATION;

BIOPSY; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; NEOPLASM STAGING; PNEUMONECTOMY; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84971281261     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0000000000000124     Document Type: Article

References (31)

1. NSCLC Meta-analyses Collaborative Group, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet. 2010;375:1267-1277.
2. Besser MJ, Shapira-Frommer R, Treves AJ, et al. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res. 2010;16:2646-2655.
3. Dudley ME, Yang JC, Sherry R, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008;26:5233-5239.
4. Shapira-Frommer R, Schachter J. Adoptive immunotherapy of advanced melanoma. Curr Treat Options Oncol. 2012;13:340-353.
5. Bernatchez C, Radvanyi LG, Hwu P. Advances in the treatment of metastatic melanoma: adoptive T-cell therapy. Semin Oncol. 2012;39:215-226.
6. Hong JJ, Rosenberg SA, Dudley ME, et al. Successful treatment of melanoma brain metastases with adoptive cell therapy. Clin Cancer Res. 2010;16:4892-4898.
7. Turner SJ, Diaz G, Cross R, et al. Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response. Immunity. 2003;18:549-559.
8. Turcotte S, Gros A, Tran E, et al. Tumor-reactive CD8 + T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res. 2014;20:331-343.
9. Markel G, Cohen-Sinai T, Besser MJ, et al. Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma. Anticancer Res. 2009;29:145-154.
10. Liu H, Zhang T, Ye J, et al. Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer. Cancer Immunol Immunother. 2012;61:1849-1856.
11. Stevanovic S, Draper LM, Langhan MM, et al. Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. J Clin Oncol. 2015;33:1543-1550.
12. Li J, Chen QY, He J, et al. Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. Oncoim-munology. 2015;4:e976507.
13. Tran E, Turcotte S, Gros A, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science. 2014;344:641-645.
14. Smith EL, Zamarin D, Lesokhin AM. Harnessing the immune system for cancer therapy. Curr Opin Oncol. 2014;26:600-607.
15. Hutchinson L. Immunotherapy: CAR-modified T cells targeting CD19-curing the incurable. Nat Rev Clin Oncol. 2014;11:683.
16. Leibovici J, Itzhaki O, Huszar M, et al. The tumor micro-environment: part 1. Immunotherapy. 2011;3:1367-1384.
17. Shi L, Wang L, Hou J, et al. Targeting roles of inflammatory microenvironment in lung cancer and metastasis. Cancer Metastasis Rev. 2015;34:319-331.
18. Besser MJ, Shoham T, Harari-Steinberg O, et al. Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies. PLoS One. 2013;8:e57922.
19. Besser MJ, Treves AJ, Itzhaki O, et al. Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical Center. Isr Med Assoc J. 2006;8:164-168.
20. Itzhaki O, Hovav E, Ziporen Y, et al. Establishment and large-scale expansion of minimally cultured "young" tumor infiltrating lymphocytes for adoptive transfer therapy. J Immunother. 2011;34:212-220.
21. Zhou J, Dudley ME, Rosenberg SA, et al. Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother. 2005;28:53-62.
22. Benlalam H, Labarriere N, Linard B, et al. Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy. Eur J Immunol. 2001;31:2007-2015.
23. Kvistborg P, Shu CJ, Heemskerk B, et al. TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology. 2012;1:409-418.
24. Kawakami Y, Wang X, Shofuda T, et al. Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes. J Immunol. 2001;166:2871-2877.
25. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679-695.
26. Maru Y. The lung metastatic niche. J Mol Med (Berl). 2015;93:1185-1192.
27. Goff SL, Smith FO, Klapper JA, et al. Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL. J Immunother. 2010;33:840-847.
28. Shlomi D, Ben-Avi R, Balmor GR, et al. Screening for lung cancer: time for large-scale screening by chest computed tomography. Eur Respir J. 2014;44:217-238.
29. Hutter J, Miller K, Moritz E. Chronic sequels after thoraco-scopic procedures for benign diseases. Eur J Cardiothorac Surg. 2000;17:687-690.
30. Krasna MJ, Deshmukh S, McLaughlin JS. Complications of thoracoscopy. Ann Thorac Surg. 1996;61:1066-1069.
31. Swanson SJ, Jaklitsch MT, Mentzer SJ, et al. Management of the solitary pulmonary nodule: role of thoracoscopy in diagnosis and therapy. Chest. 1999;116(suppl):523S-524S.